TraceLink Inc., the world’s largest track and trace network for connecting the life sciences supply chain and providing real-time information sharing for better patient outcomes, recently announced that it has acquired ROC IT Solutions, the leader in intelligent edge data capture for serialized product inventory in the pharmaceutical supply chain.
The acquisition positions TraceLink as the only end-to-end platform that enables life sciences companies to capture, process and exchange serialized product data across a digital supply chain network, while also more effectively managing warehouse product inventory at the “edge” of the supply chain.
By acquiring ROC IT and integrating EdgeTRAC into its family of serialization software, TraceLink now offers solutions for serialized receiving, picking, shipping, returns, deactivation, aggregation, de-aggregation, label printing and tag management of pharmaceutical products. The acquisition also increases TraceLink’s physical presence in the US, bringing the total number of locations to two, including its global headquarters in North Reading, MA and a new office in Pittsford, NY.
“We are pleased to welcome ROC IT’s founding members, employees and valued customers to TraceLink. As industry pioneers and market leaders, both TraceLink and ROC IT have been working together since the early days of pharmaceutical track and trace, establishing an undeniable synergy with our respective technical expertise, industry knowledge and company cultures,” said Shabbir Dahod, president & CEO, TraceLink.
“This acquisition further widens our leadership position by seamlessly merging best-of-breed serialization capabilities into a comprehensive solution set that no other provider can offer. As a result, we’ll be able to serve broader serialization challenges in the pharmaceutical industry as well as explore new capabilities for real-time information sharing that support the longer-term business and patient safety goals of our customers.”
Larry Hall, co-founder and Vice President of Sales and Operations of ROC IT, added, “By joining forces with TraceLink, we have aligned ourselves with the winning team to build an even stronger collaboration to propel the industry forward. We look forward to this next chapter with TraceLink and ensuring the ongoing success of our customers, partners and team by leveraging TraceLink’s industry expertise, proven solutions and global customer success."
The specific warehouse operations capabilities now offered by TraceLink as a result of the ROC IT acquisition include:
All existing ROC IT customers will be able to rely on TraceLink’s global customer success team for ongoing technical support and implementation assistance.
TraceLink’s serialization software, country compliance solutions and unique track and trace network is currently used by more than 650 global customers to exchange compliance data with more than 255,000 supply chain endpoints.
TraceLink is the world’s largest track and trace network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including Deloitte’s Technology Fast 500 (ranked number 149 in 2016), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information, visit www.tracelink.com.
SOURCE: TraceLink Inc.